{
    "organizations": [],
    "uuid": "2b8e8eb3828a0d54132db53357731aa49e23c213",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kobayashi-pharmaceutical-to-acquir/brief-kobayashi-pharmaceutical-to-acquire-china-based-pharmaceutical-firm-and-set-up-control-company-in-shanghai-idUSL3N1RB3O2",
    "ord_in_thread": 0,
    "title": "Kobayashi Pharmaceutical to acquire China-based pharmaceutical firm and set up control company in Shanghai",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Kobayashi Pharmaceutical Co Ltd\n* Says it will acquire 100 percent stake in Jiangsu-based pharmaceutical firm from JIANGSU ZHONGDAN GROUP CO LTD, with undisclosed price, effective June 30\n* Says it will set up a control company in Shanghai, in April, to management business in China\nSource text in Japanese: goo.gl/y1iCgh\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-29T16:11:00.000+03:00",
    "crawled": "2018-03-30T13:02:56.083+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "kobayashi",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "acquire",
        "percent",
        "stake",
        "pharmaceutical",
        "firm",
        "jiangsu",
        "zhongdan",
        "group",
        "co",
        "ltd",
        "undisclosed",
        "price",
        "effective",
        "june",
        "say",
        "set",
        "control",
        "company",
        "shanghai",
        "april",
        "management",
        "business",
        "china",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}